Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug group.

MLA

Meyer, Emmanuel, et al. “Stereotactic Radiation Therapy in the Strategy of Treatment of Metastatic Renal Cell Carcinoma: A Study of the Getug Group.” European Journal of Cancer (Oxford, England : 1990), vol. 98, July 2018, pp. 38–47. EBSCOhost, https://doi.org/10.1016/j.ejca.2018.04.008.

APA

Meyer, E., Pasquier, D., Bernadou, G., Calais, G., Maroun, P., Bossi, A., Theodore, C., Albiges, L., Stefan, D., de Crevoisier, R., Hennequin, C., Lagrange, J.-L., Grellard, J.-M., Clarisse, B., Licaj, I., Habrand, J.-L., Carrie, C., & Joly, F. (2018). Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug group. European Journal of Cancer (Oxford, England : 1990), 98, 38–47. https://doi.org/10.1016/j.ejca.2018.04.008

Chicago

Meyer, Emmanuel, David Pasquier, Guillemette Bernadou, Gilles Calais, Pierre Maroun, Alberto Bossi, Christine Theodore, et al. 2018. “Stereotactic Radiation Therapy in the Strategy of Treatment of Metastatic Renal Cell Carcinoma: A Study of the Getug Group.” European Journal of Cancer (Oxford, England : 1990) 98 (July): 38–47. doi:10.1016/j.ejca.2018.04.008.